OPTFSNA
APRE icon

Old Point Trust & Financial Services N A’s Aprea Therapeutics APRE Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$335 – 367
2024
Q1 		$335 Buy
+50
New +$311 ﹤0.01% 497

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Old Point Trust & Financial Services N A's APRE Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of Aprea Therapeutics (APRE) in Q2 2024, closing a stake of 50 shares — an estimated $335 sold.

Old Point Trust & Financial Services N A first reported a position in APRE in Q1 2024 and held it in 1 quarter. The position peaked at $335 in Q1 2024. 28 funds tracked by Wall St. Rank hold APRE as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining Aprea Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 50 Aprea Therapeutics shares in Q2 2024, an estimated $335.
  • Old Point Trust & Financial Services N A first reported a position in Aprea Therapeutics in Q1 2024 and held it in 1 quarter.
  • Old Point Trust & Financial Services N A's Aprea Therapeutics position peaked at $335 in Q1 2024.
  • 28 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.